However, in contrast, recent studies have revealed that SIRT5 expression is downregulated in advanced prostate cancer [100,101], suggesting that SIRT5 downregulation is dependent on the progression or stage of the prostate cancer cells. This evidence concerns the gene SIRT5 and prostate carcinoma.